Cochlear completes takeover of Oticon Medical cochlear implant business

Hearing implant manufacturer Cochlear has announced the completion of its acquisition of the Oticon Medical cochlear implant business from Demant, following the end of a protracted battle with competition authorities. The business, which has 20,000 implant patients, became available following Demant’s decision to discontinue work on hearing implants. Cochlear’s CEO & President Dig Howitt welcomed…

Towards 3% R&D – Medical manufacturing to propel the economy by Dig Howitt of Cochlear

Australia’s R&D effort is focused around medical technologies and here in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – Dig Howitt of Cochlear outlines the way ahead to support innovation in the sector. Cochlear has long been a pioneer in innovation. It has reshaped hearing technology and made substantial contributions…